LIMZYR Trademark

Trademark Overview

On Tuesday, April 5, 2016, a trademark application was filed for LIMZYR with the United States Patent and Trademark Office. The USPTO has given the LIMZYR trademark a serial number of 86965127. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 23, 2017. This trademark is owned by Pfizer Inc.. The LIMZYR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
limzyr

General Information

Serial Number86965127
Word MarkLIMZYR
Filing DateTuesday, April 5, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, February 23, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 11, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, February 23, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, February 23, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 25, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 25, 2016NON-FINAL ACTION E-MAILED
Monday, July 25, 2016NON-FINAL ACTION WRITTEN
Tuesday, July 19, 2016ASSIGNED TO EXAMINER
Monday, April 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 8, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

limzyr preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases